Tuesday, 8 April 2014

Global Turbochargers Market 2013 To 2019

Transparency Market Research Reports incorporated a definite business overview and investigation inclines on "Turbochargers Market". This report likewise incorporates more illumination about fundamental review of the business including definitions, requisitions and worldwide business sector industry structure. 

A turbocharger is a device used to boost the power yield of an engine. It is a type of forced induction system that compresses the air flowing into the engine, which helps increase more air flow into a cylinder. This results in more fuel addition, which in turn increases the power output of the engine per stroke. A turbocharger provides many advantages to vehicles, such as increased power output, high power to weight ratio, efficiency, and reduction in engine weight.  With the advent of technology, turbochargers are gaining popularity; increased demand for powerful vehicles is expected to boost the turbocharger market.


Based on the type of fuel, turbochargers can be classified as gasoline and diesel based, which can be used for passenger cars and commercial vehicles. Turbochargers use three technologies: variable geometry turbochargers (VGT), wastegate, and twin turbo.  VGT is mostly used in passenger vehicles, while the others are used in commercial vehicles. There are a variety of other applications for turbochargers such as power plants, generator sets, marine and other industries. Vehicle manufacturers are also considering turbochargers as a potential market in the near future; along with engines, turbochargers are expected to be a part of most commercial vehicles. 

Increased usage of vehicles in all segments, high demand for powerful engines, and the need for power efficient commercial and passenger vehicles are the drivers for this market. Developing fuel efficient turbo chargers to increase engine capacity is a challenge for the manufacturers. Countries like India, China, and Africa, where the demand for diesel engine vehicles is increasing, are expected to drive this market over the forecast period. 

Some of major players in this market are Honeywell International Inc., Rotomaster, Mitsubishi Heavy Industries, Precision Turbo and Engines, Cummins Turbo Technologies, IHI Corporation (Japan), Bosch Mahle Turbo Systems GmbH Co. KG (Germany), and others.

More Reports on Energy Market:

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 
  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  
This report provides comprehensive analysis of 
  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

Browse Market Researche Report:-

Monday, 7 April 2014

Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Research Report

Polycystic ovarian syndrome (PCOS) is an endocrine disorder observed in females during their reproductive age, due to which they may suffer from infertility problems. PCOS is characterized by a range of symptoms such as acne, menstrual irregularities, hirsutism, obesity, insulin resistance, anovulation and infertility. PCOS therapeutics include a wide a range of medications that are available in the worldwide. The global market for PCOS therapeutics can be segmented into six major categories, namely, anti-androgen drugs, contraceptive drugs, ovulation stimulants, cancer treatment drugs,diabetes treatment drugs and dietary supplements.


Major driving factors for the growth of the PCOS therapeutics market include, increasing prevalence of diabetes, rising obesity rates and increasing genetic and hormonal disorders worldwide. Diabetic and obese females are more prone to polycystic ovarian syndrome, and their rising levels will lead to more PCOS females, hence will create a demand for PCOS therapeutics worldwide. Presence of large number of off-label and generic drugs in this category may restrain the growth of this market. However, rising worldwide dissatisfaction from various off-label drugs that are available to treat PCOS will create more demand for branded drugs and thus help grow this market in future. A large number of drugs currently in clinical trials and expected to be commercialized in the near future will provide newer opportunities to this market.

Geographically, North America is the largest market for PCOS therapeutics followed by Europe. High prevalence and huge demand for diagnosis and treatments for PCOS in the region are major factors that largely contribute towards the growth of this market in these regions. Asia-Pacific market is expected to show the highest growth rate in PCOS therapeutics due to rising awareness about women healthcare and increasing affordability of the population. Major players operating in PCOS therapeutics market are AstraZeneca plc, Biocinese, Catalysis, S.L., Crinetics Pharmaceuticals, Inc., Eugonia, EffRx, Inc., Ferring Pharmaceuticals, Inc., Merck KGaA, Neurocrine Biosciences, Inc., Reliance Life Sciences Pvt. Ltd. and Shire plc.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 
  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  
This report provides comprehensive analysis of 
  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

Reasons for Buying this Report

  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth 
  • It provides a technological growth map over time to understand the industry growth rate
  • It provides a seven-year forecast assessed on the basis of how the market is predicted to grow 
  • It helps in understanding the key product segments and their future

About Us:-

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

Contact Us
Sheela AK
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
Tel: +1-518-618-1030

Browse Market Researche Report:-

Benign Prostatic Hyperplasia Therapeutics Market

Transparency Market Research
Transparency Market Research Reports included a detailed market survey and analysis trends on “Benign Prostatic Hyperplasia Therapeutics Market”. This report also includes more info about basic overview of the industry including definitions, applications and global market industry structure.

Benign prostatic hyperplasia (BPH) or benign prostatic hypertrophy, is a urological disorder that involves proliferation of the cellular components of the prostrate. BPH is the most common form of neoplasm in men. BPH results in the formation of large nodes and nodules in the periurethral region of the prostate. The significantly large nodules compresses the urethral canal that causes to partial or complete urinary tract obstruction which inhibits the normal flow of urine. Obstruction in the urinary tract further leads to complications such as urinary retention, urinary tract infections and urinary hesitancy.


Some of the medical therapies used for the treatment of BPH are as follows:
  • Alpha-Blockers
  • 5- Alpha-reductase inhibitors (5-ARIs)
  • Alpha-Adrenergic Blockers
  • Phosphodiesterase-5 Enzyme Inhibitors
  • Anticholinergic Agents
  • Nonselective alpha-blockers
Some of the surgical interventions used of the treatment of BPH are as follows:
  • Holmium Laser Resection of the Prostate (HoLRP)
  • Open prostatectomy
  • Photoselective vaporization of the prostate (PVP)
  • Transurethral holmium laser ablation of the prostate (HoLAP)
  • Transurethral resection of the prostate (TURP)
  • Transurethral vaporization of the prostate (TUVP)
  • Transurethral incision of the prostate (TUIP)
Geographically, North America is the leading market due to high prevalence rate of benign prostatic hyperplasia and lower urinary tract symptoms (LUTS). Various studies reports that 90% of men in the U.S., aged between 45 and 80 years suffer from some type of LUTS and approximately 14 million men in the U.S. have symptoms of BPH. Asia-Pacific is also expected to witness a significant growth due to the rise in various urological disorders and complications. However, BPH tends to be more progressive in African-American men owing to the presence of high testosterone level in their body.


Rise in geriatric population is expected to be one of the major driver that might drive the market. Additionally, increased awareness for prostate cancer and other urological disorders, are also expected to fuel the growth of the global BPH therapeutics market. However, high adoption rate of minimally invasive surgeries such as transurethral microwave thermotherapy (TUMT), laparoscopic prostatectomy and transurethral needle ablation (TUNA) might impede the growth of the BPH therapeutics market.

Some of the key players in the benign prostatic hyperplasia (BPH) therapeutics Market are AEternaZentaris Inc., Astellas Pharma Inc., Eli Lilly and Company, EndoCeutics, Inc., IntelGenx Technologies Corp., Ipsen S.A., Nymox Pharmaceutical Corporation, Protox Therapeutics Inc. and Quest PharmaTech Inc.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 
  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  
This report provides comprehensive analysis of 

  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

Reasons for Buying this Report
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth 
  • It provides a technological growth map over time to understand the industry growth rate
  • It provides a seven-year forecast assessed on the basis of how the market is predicted to grow 
  • It helps in understanding the key product segments and their future
·   More Reports On Pharmaceutical Market: - http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

Browse Market Researche Report:-

Zero-Calorie or Low-Calorie Food Market - Global Analysis, Size, Share and Forecast, 2013-2019

Transparency Market Research Report Added “Zero-Calorie or Low-Calorie Food Market” to its database. Low or Zero-Calorie Food is the major growing segment in the global health food market. The growing health concern and changing consumer’s lifestyle, which is moving them away from consuming high-calorie foods, acts as major driving factor for the industry. Other major factors contributing to market growth are increasing diabetes concerns and rising obesity levels. In recent times, people have started consuming low or zero-calorie products as precautionary measures to avoid obesity and diabetes, which could further lead to more fatal conditions. Over promising of the brands acts as a major factor affecting the brand value of the product thus impacting the demand of such products. 


Zero or low calorie foods products are available in almost all general food segments such as dairy products, baked products, confectionary and dietary beverages. The U.S. is the largest market for zero or low-calorie food followed by the European countries. The developing nations in Asia-Pacific region are expected to show high growth in the next five years. Some of the major companies operating in the market are PepsiCo, Coca-Cola, Nestle, Danone, Bernard Food Industries and Dr Pepper Snapple Group. 

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 
  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  
This report provides comprehensive analysis of 
  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

Reasons for Buying this Report

  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth 
  • It provides a technological growth map over time to understand the industry growth rate
  • It provides a seven-year forecast assessed on the basis of how the market is predicted to grow 
  • It helps in understanding the key product segments and their future        

Browse Market Researche Report:-

Wednesday, 2 April 2014

Deep Study on 'Erythropoietin Market' Research Analysis, Size, Trends & Forecast - 2013-2019

Transparency Market Research Reports included a detailed market survey and analysis trends on “Erythropoietin Market”. This report also includes more info about basic overview of the industry including definitions, applications and global market industry structure.

Erythropoietin is a type of a glycoprotein produced by body that controls red blood cell production in the body and is produced in kidneys. Kidney cells responsible for production of erythropoietin are sensitive to oxygen levels in the blood. Low levels of oxygen in the blood trigger the production and release of erythropoietin. Erythropoietin stimulates the bone marrow to produce red blood cells that ultimately carries oxygen and maintains the oxygen levels in the body. Thenormal range of erythropoietin is 4 to 24 mU/ml.


Erythropoietin tests detects abnormal levels of erythropoietin in the blood thus indicating kidney diseases, bone marrow disorders and excess erythropoietin production.Erythropoietin is also used to correct anemic conditions by stimulating red blood cell production.  Increasing incidences of anemia globally mainly resulting from chemotherapy and rapidly increasing morbidity rate of kidney disorders are driving the growth of the global erythropoietin market. While on the other hand, erythropoietin market has reached to saturation in developed countries thus restraining the growth of this market to some extent. Synthetic erythropoietin is produced using DNA recombinant technology.

Erythropoietin market can be categorized on the basis of types of synthetic erythropoietin as follows:
  • Epoetin-alfa
  • Epoetin-beta
  • Epoetin-omega
  • Epoetin-delta
  • Darbepoetin-alfa
Further, based on application erythropoietin market is segmented as,

  • Oncology diseases
  • End stage renal disease (ESRD)
  • Pre-dialysis
Currently, North America dominatesthe erythropoietin market and is followed by Europe due high spending capacity in the healthcare infrastructure in these regions. Asia-Pacific is a promising market for erythropoietin and is expected to undergo rapid market growth due to increase in purchasing power, rapidly improving healthcare infrastructure and increased medical tourism and the available treatments. Some of the major companies contributing to this market include Hospira Inc., Amgen Inc., Roche Diagnostics and Johnson & Johnson. 


This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World   
This report provides comprehensive analysis of 

  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 


Reasons for Buying this Report

  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth 
  • It provides a technological growth map over time to understand the industry growth rate
  • It provides a seven-year forecast assessed on the basis of how the market is predicted to grow 

About Us:-

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Contact Us
Sheela AK
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
Tel: +1-518-618-1030

Browse Market Researche Report:-

Deep Study on 'Enzyme Linked Immunosorbent Assay Technologies Market' Research Report - 2013-2019

Transparency Market Research Reports included a detailed market survey and analysis trends on “Enzyme-Linked Immunosorbent Assay Technologies Market”. This report also includes more info about basic overview of the industry including definitions, applications and global market industry structure.

Enzyme-Linked Immunosorbent Assay (ELISA) is a test performed to detect the presence of antibodies in a biological liquid sample.  ELISA is used as quality control check in many industry and as a diagnostic tool in plant pathology and in medicine. 


Though the latest emerging technology i.e. themultiplex proteomic array platform is rapidly replacing the ELISA, its market continues to grow since it is being preferred as a secondary validation tool to confirm the results of multiplex proteomic platform. Emergence of cost effective technologies and laboratory automation are some of the major factorsthat are driving the global ELISA market towards growth. The existing ELISA manufacturers are currently facing price pressures due to increase in the number of market players, thereby increasing competitive rivalry. In order to survive the market competition, many market players are have begun to shift their focus on niche marketsand have increased their efforts in developing innovative solutions. 

The ELISA market can be segmented based on test types such as:
·         Sandwich ELISA
·         Indirect ELISA
·         Multiple and portable ELISA
·         Competitive ELISA

This market is further segmented on the basis of applications, such as:
·         Immunology
·         Inflammation
·         Infectious diseases
·         Cancer
·         Protein quantitation

Geographically, the global enzyme-linked immunosorbent assay market can be categorized into North America, Europe, Asia-Pacific and rest of the world regions. North America,particularly the United States currently leads this marketand is followed by Europe due to widespread existence and early adoption of highly developed technologies and supportive economy. Asia-Pacific is a promising market for ELISA kits and is expected to undergo rapid market growth. Especially countries like China and India are promising regions, reason being rapidly growing medical tourism industry in India and China will increase the use of ELISA test as a diagnostic tool. 

Some of the market players leading the enzyme-linked immunosorbent assay (ELISA) market include Ortho-Clinical Diagnostics, Inc., Thermo Fisher Scientific. Inc., Life Technologies Corporation and ZEUS Scientific, Inc. 


This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

·         North America 
·         Asia Pacific 
·         Europe
·         Rest of the World  

This report provides comprehensive analysis of 

·         Market growth drivers 
·         Factors limiting market growth
·         Current market trends 
·         Market structure
·         Market projections for upcoming years 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players.


Reasons for Buying this Report
·         This report provides pin-point analysis for changing competitive dynamics
·         It provides a forward looking perspective on different factors driving or restraining market growth 
·         It provides a technological growth map over time to understand the industry growth rate
·         It provides a seven-year forecast assessed on the basis of how the market is predicted to grow 
·         It helps in understanding the key product segments and their future
·         It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments


About Us:-

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Contact Us
Sheela AK
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
Tel: +1-518-618-1030

Browse Market Researche Report:-

Deep Study on 'Dual Chamber Injectors And Syringes Market' Research Analysis, Overview, Trends & Forecast-2013-2019

Transparency Market Research Reports included a detailed market survey and analysis trends on “Dual Chamber Injectors and Syringes Market”. This report also includes more info about basic overview of the industry including definitions, applications and global market industry structure.

Dual chamber injectors and syringes aremedical devices used to store active pharmaceutical components or biological substances (such as tissue, blood or serum) that are not stable for extended period of time. These devices helps to maintain sterility of drugs before the time of injection in order to avoid drug loss.For example, liquid proteins drugs require refrigeration before dispensing thus, dual chamber injectors and syringes helps to manage proper storage condition of these drugs. Thus, proper storage of these drugs reduces the adverse effects of drug delivery.


Advancement in technology has introduced improved arrangement for liquid component in injectors and syringes. This advancement in technology may attract more number of customers to use these devices and hence drive the growth of these markets. Technology advancement has been further aided by launch of EZMix dual or multi chamber prefilled syringes by Unilife. EZMix serve as a safe and efficient system for reconstitution and delivery of injectable therapies. In addition, need for storage of biological substances and lyophilized drugs at freezing temperature before the use may drive the growth of dual chamber injectors and syringes markets. However, high cost of these devices may restrain the market growth.


The global Dual Chamber Injectors and Syringe marketcan be segmented as follows:

  • Dual Chamber Syringe Devices
    • Caverject
    • Liquid Dry
    • Lyo-Ject
  • Dual Chamber Syringe Devices
    • LyoTwist Trio/Vario
    • UnoPen Memo
    • MiniQuick
    • UnifillEZMix Dual Chamber Safety Syringe
Geographically, North America and Europe dominates theglobal Dual Chamber Injectors and Syringe marketowing to increasing need to store lyophilized drug and maintain the stability of biological substances.In addition, Asia-Pacific region is anemerging market for the global dual chamber injectors and syringe.
Some of the key players contributing to the global Dual Chamber Injectors and Syringe marketcomprises Amylin Pharmaceuticals, LLC, Becton Dickinson, Hospira, SHL Medical, Vetter Pharma, and Ypsomed.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 
  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  
This report provides comprehensive analysis of 

  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

 Reasons for Buying this Report

  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth 
  • It provides a technological growth map over time to understand the industry growth rate
  • It provides a seven-year forecast assessed on the basis of how the market is predicted to grow 

About Us:-

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

Contact Us
Sheela AK
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
Tel: +1-518-618-1030

Browse Market Researche Report:-